Structures by: Kettmann V.
Total: 56
Li2 Mg2 (S O4)3
Li2Mg2O12S3
Acta Crystallographica C (39,1983-) (1988) 44, 1887-1889
a=12.165Å b=8.538Å c=8.689Å
α=90° β=90° γ=90°
Trans-5,6a-Dihydro-5-phenylisoindolo[1,2-b]benz[1,3]oxazepin-11-one
C22H17NO2
Acta Crystallographica Section E (2001) 57, 7 o612-o614
a=10.799(3)Å b=12.113(4)Å c=13.775(4)Å
α=104.47(4)° β=99.40(3)° γ=101.26(5)°
Methyl (4-formyl-2-methoxycarbonyl-1-pyrrolyl)acetate
C10H11NO5
Acta Crystallographica Section E (2001) 57, 5 o404-o405
a=5.1010(10)Å b=20.098(4)Å c=10.461(2)Å
α=90.00° β=90.31(3)° γ=90.00°
5-Amino-4-methylsulfonyl-1-phenyl-1H-pyrazole
C10H11N3O2S
Acta Crystallographica Section E (2005) 61, 11 o3852-o3854
a=8.083(2)Å b=12.274(3)Å c=11.040(3)Å
α=90.00° β=95.20(3)° γ=90.00°
4,4-Dinitro-5,6,7,8,9,10-hexahydro-4H-cyclonona[d]isoxazole
C10H13N3O5
Acta Crystallographica Section E (2005) 61, 4 o808-o810
a=8.735(2)Å b=16.569(4)Å c=8.764(2)Å
α=90.00° β=113.81(4)° γ=90.00°
5-Methyl-1,2,4-triazolo[1,5-a]pyrimidine-6-carbonitrile
C7H5N5
Acta Crystallographica Section E (2006) 62, 4 o1252-o1253
a=7.105(2)Å b=6.413(2)Å c=8.190(3)Å
α=90.00° β=96.82(3)° γ=90.00°
C39H28Cu2N9O2S
C39H28Cu2N9O2S
Acta Crystallographica Section C (1994) 50, 3 380-383
a=12.363(15)Å b=13.134(14)Å c=13.584(12)Å
α=65.57(7)° β=64.92(8)° γ=65.18(8)°
2-(1-Methyl-1,2-dihydropyridine-2-iminomethylene)propanedinitrile
C10H8N4
Acta Crystallographica Section C (1998) 54, 6 785-787
a=11.686(8)Å b=3.956(2)Å c=20.404(13)Å
α=90.00° β=106.06(7)° γ=90.00°
2-(2-thienyl)-3-(5-phenyl-2-furyl)propenenitrile
C17H11NOS
Acta Crystallographica Section C (1998) 54, 6 787-788
a=10.456(2)Å b=11.277(2)Å c=12.676(3)Å
α=90.00° β=112.40(3)° γ=90.00°
C4H7N3O2
C4H7N3O2
Acta Crystallographica Section C (1995) 51, 6 1133-1135
a=6.003(5)Å b=8.301(6)Å c=11.432(10)Å
α=90.° β=94.39(5)° γ=90.°
C13H14N2O3S
C13H14N2O3S
Acta Crystallographica Section C (1996) 52, 6 1496-1499
a=7.442(3)Å b=10.255(5)Å c=16.128(8)Å
α=90° β=90.92(5)° γ=90°
C37H40N2O6
C37H40N2O6
Acta Crystallographica Section C (1996) 52, 6 1479-1482
a=10.749(6)Å b=13.068(5)Å c=22.643(9)Å
α=90° β=90° γ=90°
Methyl 9-Methyl-11-thioxo-8-oxa-12-acetyl-10,12-diazatricyclo[7.3.1.0^2,7^] trideca-2,4,6-triene-13-carboxylate
C15H16N2O4S
Acta Crystallographica Section C (1997) 53, 10 1493-1495
a=8.962(3)Å b=9.651(4)Å c=10.009(4)Å
α=68.45(3)° β=71.46(3)° γ=81.52(3)°
6-(2-Nitroprop-2-yl)quinoline-5-carbonitrile
C13H11N3O2
Acta Crystallographica Section C (1999) 55, 7 1101-1103
a=6.842(2)Å b=12.156(3)Å c=14.184(3)Å
α=90.00° β=92.32(3)° γ=90.00°
4,6,7,8,8a,9-hexahydrothieno[2,3-f]indolizine-6,9-dione
C10H9NO2S
Acta Crystallographica Section C (1999) 55, 7 1103-1105
a=8.067(3)Å b=9.699(4)Å c=12.191(4)Å
α=90.00° β=100.19(3)° γ=90.00°
C24H39ClN2O3
C24H39ClN2O3
Acta Crystallographica Section C (1993) 49, 5 908-911
a=9.114(7)Å b=18.747(11)Å c=14.185(9)Å
α=90° β=104.57(6)° γ=90°
C10H18N2O7
C10H18N2O7
Acta Crystallographica Section C (1993) 49, 6 1182-1184
a=7.076(5)Å b=8.218(7)Å c=10.353(8)Å
α=90° β=105.20(4)° γ=90°
C16H20N6O4S
C16H20N6O4S
Acta Crystallographica Section C (1995) 51, 9 1861-1864
a=23.875(11)Å b=22.954(10)Å c=11.877(5)Å
α=90° β=90° γ=90°
C10H10O4
C10H10O4
Acta Crystallographica Section C (1992) 48, 6 1063-1065
a=9.266(7)Å b=14.570(10)Å c=7.404(5)Å
α=90° β=108.60(6)° γ=90°
C16H17CuN5O3
C16H17CuN5O3
Acta Crystallographica Section C (1993) 49, 11 1932-1934
a=5.100(2)Å b=10.051(4)Å c=16.453(7)Å
α=90.0° β=94.82(5)° γ=90.0°
C24H39N2O31,Cl11
C24H39N2O31,Cl11
Acta Crystallographica Section C (1993) 49, 6 1080-1082
a=11.749(7)Å b=7.083(4)Å c=28.76(2)Å
α=90.° β=97.15(6)° γ=90.°
C2H12N6NiS2
C2H12N6NiS2
Acta Crystallographica Section C (1993) 49, 3 535-536
a=11.359(9)Å b=8.128(7)Å c=5.608(5)Å
α=90° β=75.42(5)° γ=90°
C39H24Cu2N9S0.9Se1.1,0.5(C2H6O1)
C39H24Cu2N9S0.9Se1.1,0.5(C2H6O1)
Acta Crystallographica Section C (1993) 49, 8 1476-1479
a=17.792(18)Å b=16.491(18)Å c=24.28(4)Å
α=90° β=94.01(10)° γ=90°
C39H34Cu2N9O5
C39H34Cu2N9O5
Acta Crystallographica Section C (1993) 49, 8 1479-1482
a=11.483(15)Å b=12.066(15)Å c=15.586(8)Å
α=107.32(10)° β=107.11(9)° γ=106.79(9)°
2-(2-Benzoxazolyl)-3-(5-diethylamino-2-furyl)propenenitrile
C18H17N3O2
Acta Crystallographica Section C (1997) 53, 9 1358-1359
a=6.5270(10)Å b=17.257(3)Å c=13.990(3)Å
α=90.00° β=93.58(3)° γ=90.00°
C30H38N4O4PRh
C30H38N4O4PRh
Acta Crystallographica Section C (1996) 52, 6 1399-1401
a=8.696(3)Å b=10.421(4)Å c=17.113(8)Å
α=76.63(5)° β=87.31(6)° γ=72.23(5)°
C28H34N4O4PRh
C28H34N4O4PRh
Acta Crystallographica Section C (1994) 50, 8 1239-1241
a=8.707(4)Å b=15.490(10)Å c=10.476(5)Å
α=90° β=105.74(6)° γ=90°
Methyl 1,4,5,6-tetrahydro-2-methyl-4-(2-nitrophenyl)-6-oxo-pyridine-3- carboxylate
C14H14N2O5
Acta Crystallographica Section C (1999) 55, 4 661-663
a=7.328(8)Å b=8.729(9)Å c=11.513(11)Å
α=95.83(7)° β=107.27(8)° γ=97.34(7)°
Ethyl [5-(2-hydroxyphenyl)-3-methyl-4,5-dihydro-1H-pyrazol-1-yl]oxoacetate
C14H16N2O4
Acta Crystallographica Section E (2007) 63, 5 o2607-o2608
a=17.133(3)Å b=17.062(3)Å c=20.130(4)Å
α=90.00° β=93.02(4)° γ=90.00°
1-Methyl-6-nitro-1H-benzimidazole
C8H7N3O2
Acta Crystallographica Section E (2008) 64, 4 o671-o672
a=12.852(3)Å b=7.043(2)Å c=17.690(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 6-ethoxycarbonylmethyl-4-(2-hydroxyphenyl)-2-oxo-1,2,3,4- tetrahydropyrimidine-5-carboxylate
C17H20N2O6
Acta Crystallographica Section E (2008) 64, 6 o1092
a=8.783(2)Å b=9.336(3)Å c=11.415(4)Å
α=71.47(4)° β=82.78(5)° γ=75.05(4)°
3-Acetyl-4-aminoquinoline
C11H10N2O
Acta Crystallographica Section E (2007) 63, 3 o1164-o1166
a=30.815(6)Å b=8.884(2)Å c=13.305(3)Å
α=90.00° β=90.00° γ=90.00°
3-[(2,3-Diphenylquinoxalin-5-ylamino)methylene]pentane-2,4-dione
C26H21N3O2
Acta Crystallographica Section E (2007) 63, 6 o3005-o3006
a=12.326(3)Å b=10.726(2)Å c=15.999(3)Å
α=90.00° β=98.43(3)° γ=90.00°
4-[(5<i>R</i>*,10<i>bR</i>*)-2-Methyl-1,10b-dihydropyrazolo[1,5- <i>c</i>][1,3]benzoxazin-5-yl]benzoic acid
C18H16N2O3
Acta Crystallographica Section E (2008) 64, 3 o563
a=6.638(2)Å b=10.997(3)Å c=11.141(3)Å
α=70.78(2)° β=80.85(3)° γ=79.15(2)°
Methyl 6-methoxycarbonylmethyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine- 5-carboxylate
C15H16N2O5
Acta Crystallographica Section E (2008) 64, 9 o1776
a=23.498(5)Å b=12.072(2)Å c=10.933(5)Å
α=90.00° β=99.15(2)° γ=90.00°
3-Phenylazo-2-(4-methoxyphenylamino)-2-penten-4-one
C18H19N3O2
Acta Crystallographica Section C (2001) 57, 6 737-739
a=11.525(5)Å b=14.465(6)Å c=9.761(3)Å
α=90.00° β=92.82(4)° γ=90.00°
Cis-6-Phenyl-4bH,6H,11H,13H-isoindolo[1,2-c]benz[2,4]oxazepin-13-one
C22H17NO2
Acta Crystallographica Section C (2001) 57, 6 735-736
a=7.153(3)Å b=8.961(4)Å c=13.156(7)Å
α=92.69(5)° β=106.83(5)° γ=96.79(4)°
3-Butyl-1-(5-nitrobenzo[c][1,2]thiazol-3-yl)-3-phenyltriazene
C17H17N5O2S
Acta Crystallographica Section C (2004) 60, 2 o143-o145
a=9.702(5)Å b=9.750(5)Å c=10.106(6)Å
α=83.24(5)° β=79.72(4)° γ=72.92(4)°
[Rh(C~4~H~7~N~2~O~2~)~2~(C~18~H~15~P)(C~8~H~5~)].CH~2~Cl~2~
[Rh(C~4~H~7~N~2~O~2~)~2~(C~18~H~15~P)(C~8~H~5~)].CH~2~Cl~2~
Acta Crystallographica Section C (1995) 51, 2 210-213
a=20.378(9)Å b=9.914(5)Å c=17.272(8)Å
α=90.° β=103.00(6)° γ=90.°
4-hydroxy-7-methoxy-2-methyl-5H-1-benzopyrano[4,3-b]pyridin-5-one
C14H11NO4
Acta Crystallographica Section C (2001) 57, 5 590-592
a=7.333(3)Å b=9.389(4)Å c=17.161(7)Å
α=90° β=95.05(4)° γ=90°
Dimethyl (1-Methyl-5-benzimidazolyl)aminomethylenepropanedioate Monohydrate
C14H15N3O4.H2O
Acta Crystallographica Section C (2000) 56, 8 1007-1008
a=20.012(8)Å b=8.929(3)Å c=16.473(5)Å
α=90.00° β=93.34(4)° γ=90.00°
N-{(1E)-Amino[3-methyl-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1- yl]methylene}-1H-imidazole-1-carboxamide
C16H18N6O
Acta Crystallographica Section C (2004) 60, 6 o431-o433
a=32.322(5)Å b=32.322(5)Å c=8.084(2)Å
α=90.00° β=90.00° γ=120.00°
2-(phenylaminomethylidene)cyclohexane-1,3-dione
C13H13N1O2
Acta Crystallographica Section C (2004) 60, 4 o252-o254
a=5.678(2)Å b=8.424(3)Å c=12.404(5)Å
α=100.17(3)° β=93.85(3)° γ=107.96(4)°
C28H25N3O5
C28H25N3O5
Acta Crystallographica Section C (1994) 50, 11 1784-1786
a=17.714(9)Å b=7.571(5)Å c=17.974(10)Å
α=90.° β=103.85(6)° γ=90.°
4,5-Dihydro-3-methyl-5-(4-methylphenyl)-1H-pyrazole-1-carboxamidinium acetate acetone hemisolvate
C12H17N41,C2H3O21,0.5C3H6O
Acta Crystallographica Section C (2002) 58, 7 o423-o424
a=27.679(11)Å b=8.126(4)Å c=18.776(9)Å
α=90.00° β=129.15(6)° γ=90.00°
4,5-Dihydro-3-methyl-5-(4-methylphenyl)-1H-pyrazole-1-carboxamide
C12H15N3O
Acta Crystallographica Section C (2003) 59, 8 o419-o421
a=6.080(3)Å b=6.815(3)Å c=14.314(5)Å
α=96.86(4)° β=91.28(4)° γ=101.40(5)°
C28H32N4O4PRh
C28H32N4O4PRh
Acta Crystallographica Section C (1994) 50, 9 1427-1430
a=9.703(5)Å b=11.014(4)Å c=25.218(9)Å
α=90.° β=97.91(4)° γ=90.°
(6R*,16R*)-9,14-Dihydro-6-methyl-6,16-methano-6H,16H-[2,4]benzo- thiazepino[3,4-d][1,3,5]benzoxadiazocine hydrobromide 0.5 dimethylformamide
C19H19N2OS,Br,0.5C3H7NO
Acta Crystallographica Section C (2000) 56, 9 1115-1116
a=18.612(8)Å b=19.807(9)Å c=11.087(5)Å
α=90.00° β=95.94(3)° γ=90.00°
C11H9Cu1N2O41,K11
C11H9Cu1N2O41,K11
Acta Crystallographica Section C (1990) 46, 6 1119-1121
a=7.925(3)Å b=17.144(8)Å c=9.231(5)Å
α=90° β=104.53(5)° γ=90°
Dimethyl 2-[(2-Methoxycarbonyl-1-methoxycarbonylmethyl-4-pyrrolyl)methylene]- propanedioate
C15H17NO8
Acta Crystallographica Section C (2001) 57, 8 973-974
a=9.906(4)Å b=12.528(5)Å c=13.991(5)Å
α=90.00° β=105.44(4)° γ=90.00°
1-Methyl-1H-imidazo[5,4-f]quinolin-6-ium chloride monohydrate
C11H10N3,Cl,H2O
Acta Crystallographica Section C (2002) 58, 6 o365-o366
a=7.544(5)Å b=9.084(6)Å c=9.152(8)Å
α=72.65(6)° β=66.61(5)° γ=76.96(7)°
5-Amino-1-methyl-1<i>H</i>-benzimidazole
C8H9N3
Acta Crystallographica Section E (2009) 65, 8 o1788
a=5.9128(2)Å b=8.8215(3)Å c=14.8418(6)Å
α=90.00° β=100.129(3)° γ=90.00°
2-Methyl-1,10b-dihydro-5<i>H</i>-pyrazolo[1,5-<i>c</i>][1,3]benzoxazin-5-one
C11H10N2O2
Acta Crystallographica Section E (2009) 65, 5 o984
a=7.240(2)Å b=8.835(2)Å c=15.755(4)Å
α=90° β=90° γ=90°
(5<i>R</i>*,11<i>R</i>*)-5-Methyl-1,2-dihydro-5,11-methano- 5<i>H</i>,11<i>H</i>-1,3-thiazolo[2,3-<i>d</i>][1,3,5]benzoxadiazocine
C13H14N2OS
Acta Crystallographica Section E (2009) 65, 11 o2967
a=14.307(2)Å b=5.9910(10)Å c=15.203(2)Å
α=90.00° β=113.360(10)° γ=90.00°
<i>rac</i>-2-Methyl-3,4,5,6-tetrahydro-2<i>H</i>-2,6-methano-1,3- benzoxazocin-4-one
C12H13NO2
Acta Crystallographica Section E (2010) 66, 6 o1402
a=5.5640(10)Å b=9.820(2)Å c=10.596(2)Å
α=108.730(10)° β=95.09(2)° γ=103.600(10)°
Methyl 5'-(2-hydroxyphenyl)-4',5',6',7'-tetrahydrospiro[2<i>H</i>-1-benzopyran-2,7'- 1,2,4-triazolo[1,5-<i>a</i>]pyrimidine]-3-carboxylate
C21H18N4O4
Acta Crystallographica Section E (2011) 67, 1 o92
a=19.337(6)Å b=14.824(5)Å c=13.932(5)Å
α=90.00° β=97.940(10)° γ=90.00°